HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Holger Jensen Selected Research

Ovarian Epithelial Carcinoma

1/2019Intraperitoneal α-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Holger Jensen Research Topics

Disease

32Neoplasms (Cancer)
04/2024 - 09/2003
17Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 09/2003
6Carcinoma (Carcinomatosis)
01/2017 - 10/2007
5Ascites
03/2013 - 11/2005
3Neoplasm Metastasis (Metastasis)
01/2022 - 08/2014
3Body Weight (Weight, Body)
02/2020 - 04/2013
2Prostatic Neoplasms (Prostate Cancer)
02/2024 - 02/2020
2Residual Neoplasm
02/2020 - 11/2015
1Fatigue
01/2019
1Ovarian Epithelial Carcinoma
01/2019
1Intestinal Perforation
01/2019
1Neoplasm Micrometastasis
08/2013
1Weight Loss (Weight Reduction)
04/2013
1Disease Progression
03/2013
1Colorectal Neoplasms (Colorectal Cancer)
08/2007

Drug/Important Bio-Agent (IBA)

12Astatine-211IBA
04/2024 - 10/2007
10Monoclonal AntibodiesIBA
04/2023 - 09/2003
7211At-labeled monoclonal antibody MX35IBA
01/2021 - 08/2006
6AntibodiesIBA
01/2021 - 09/2003
3AntigensIBA
02/2020 - 08/2007
3AstatineIBA
03/2016 - 12/2009
3Immunoconjugates (Immunoconjugate)IBA
03/2016 - 12/2005
2Neoplasm Antigens (Tumor Antigens)IBA
04/2023 - 01/2015
2Radioisotopes (Radionuclides)IBA
02/2015 - 04/2013
2EpitopesIBA
01/2015 - 09/2003
1Rituximab (Mabthera)FDA Link
01/2021
1farletuzumabIBA
01/2021
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2020
1Indicators and Reagents (Reagents)IBA
01/2019
1TinIBA
03/2016
1BR96 monoclonal antibodyIBA
08/2014
1Reducing AgentsIBA
08/2014
1HalogensIBA
08/2014
1Lutetium-177IBA
08/2014
1Eosine Yellowish-(YS) (Eosin)IBA
08/2013
1Hematoxylin (Haematoxylon)IBA
08/2013
1Lewis Y antigenIBA
04/2013
1Proteins (Proteins, Gene)FDA Link
04/2013
1procaine isothiocyanate (PRIT)IBA
03/2013
1Lysine (L-Lysine)FDA Link
12/2011
1AvidinIBA
12/2011
1N 30IBA
06/2010
1Trastuzumab (Herceptin)FDA Link
10/2007

Therapy/Procedure

19Radioimmunotherapy
04/2023 - 09/2003
17Therapeutics
04/2024 - 07/2009
8Aftercare (After-Treatment)
02/2020 - 11/2005
3Drug Therapy (Chemotherapy)
01/2019 - 07/2009
2Intravenous Injections
01/2021 - 01/2017
2Catheters
01/2019 - 07/2009
1Castration
02/2020
1Transcutaneous Electric Nerve Stimulation (TENS)
08/2013